- KR₩189bn
- KR₩202bn
- KR₩191bn
- 74
- 31
- 14
- 32
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.92 | ||
| Price to Tang. Book | 3 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1 | ||
| EV to EBITDA | 16.06 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 4.06% | ||
| Return on Equity | -1.55% | ||
| Operating Margin | 2.71% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 107,818.82 | 111,761.63 | 133,343.23 | 154,040.84 | 190,597.48 | n/a | n/a | 11.45% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -31.99 | +29.6 | -40.41 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
UBCARE CO., LTD. is a Korea-based company engaged in the provision of healthcare solutions. The Company mainly operates in two segments. The Medical Information Platform segment provides integrated information solutions providing medical services. The Personal Health Information Management Platform segment provides health management services. In addition, the Company distributes medical instrument and green agricultural products, as well as operates electronic commerce business.
Directors
- Sang Gyeong Lee CEO (48)
- Tae Man Gwon OTH (52)
- Dong Hwan Ahn OTH (56)
- Gwang Hyeon Jeon OTH (56)
- Jin Wuk Choi NID (50)
- Yin Yeong Kim NID (47)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 2nd, 1994
- Public Since
- May 2nd, 1997
- No. of Shareholders
- 30,953
- No. of Employees
- 197
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
Korea Exchange - KOSDAQ- Shares in Issue
- 50,742,642
- Address
- 10F, 1 Cha, Woorim E-Biz Center,, SEOUL, 07335
- Web
- https://www.ubcare.co.kr/
- Phone
- +82 221055000
- Auditors
- Ernst & Young Han Young
Upcoming Events for 032620
Similar to 032620
Actoz Soft Co
Korea Exchange - KOSDAQ
Ahnlab
Korea Exchange - KOSDAQ
Alchera
Korea Exchange - KOSDAQ
Alticast
Korea Exchange - KOSDAQ
APS
Korea Exchange - KOSDAQ
FAQ
As of Today at 23:51 UTC, shares in UBCare Co are trading at KR₩3,755. This share price information is delayed by 15 minutes.
Shares in UBCare Co last closed at KR₩3,755 and the price had moved by -20.89% over the past 365 days. In terms of relative price strength the UBCare Co share price has underperformed the FTSE Developed Asia Pacific Index by -19.98% over the past year.
There is no consensus recommendation for this security.
Find out moreThe UBCare Co dividend yield is 0.8% based on the trailing twelve month period.
Last year, UBCare Co paid a total dividend of KR₩30, and it currently has a trailing dividend yield of 0.8%. We do not have any data on when UBCare Co is to next pay dividends.
We do not have data on when UBCare Co is to next pay dividends. The historic dividend yield on UBCare Co shares is currently 0.8%.
To buy shares in UBCare Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩3,755, shares in UBCare Co had a market capitalisation of KR₩189bn.
Here are the trading details for UBCare Co:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 032620
Based on an overall assessment of its quality, value and momentum UBCare Co is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like UBCare Co. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +7.25%.
As of the last closing price of KR₩3,755, shares in UBCare Co were trading -1.21% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The UBCare Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩3,755.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
UBCare Co's management team is headed by:
- Sang Gyeong Lee - CEO
- Tae Man Gwon - OTH
- Dong Hwan Ahn - OTH
- Gwang Hyeon Jeon - OTH
- Jin Wuk Choi - NID
- Yin Yeong Kim - NID